Benzinga · Aug 10, 2026
Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $13
Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $18 to $13.
OF
NASDAQ · OFIX
Orthofix Medical Inc.
Healthcare · Medical - Devices
$10.22
Up+$0.19 (+1.89%)
Updated Aug 19, 2026, 11:27 AM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 622.51M
- P/E ratio
- -5.25
- Dividend yield
- 0.00%
- 52-week range
- $8.85 – $16.99
- Volume
- 234.06K
- Avg. volume
- 261.03K
Price performance
OFIX price history
1M range · 0 trading sessions · Daily adjusted prices
OFIX does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest OFIX news
The latest Smart Investors Daily articles mentioning OFIX.
Stock researchCompany · Overview
OFIX research
Overview
Company profile and research snapshot.
Company profile
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $20.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2026 | Canaccord Genuity | Buy | — |
| Jul 6, 2026 | Barrington Research | Outperform | — |
| May 22, 2026 | Canaccord Genuity | Buy | — |
| May 22, 2026 | Stifel | Buy | — |
| May 22, 2026 | Barrington Research | Outperform | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 5, 2026
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million. Caris Life Sciences (NASDAQ:CAI)
ChartMill · Aug 5, 2026
Orthofix Medical (NASDAQ:OFIX) Jumps on Q2 Earnings Beat and Raised Guidance
Orthofix Medical (OFIX) beats Q2 profit estimates, raises full-year 2026 guidance; stock up ~9.6% premarket despite in-line revenue.
SeekingAlpha · Aug 5, 2026
Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript
Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call August 5, 2026 8:30 AM EDTCompany ParticipantsJulie Dewey - Chief Investor Relations & Communications...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
